Intravenous Immunoglobulin in the Treatment of Patient with Acute Disseminated Encephalomyelitis: Case Report
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2015, Vol 5, Issue 5
Abstract
Background: Acute disseminated encephalomyelitis (ADEM) is a monophasic process nevertheless sometimes aggravated by relapses (so-called multiphase course of the disease). The treatment of ADEM must be targeted at reducing clinical manifestations of the disease and prevention of its relapses. Case Presentation: We report a 42-year old woman with a diagnosis of acute disseminated encephalomyelitis. The patient received intravenous immunoglobulin in the dose of 0.4 g per 1 kg of body mass within 5 days 1 month after the hormonal pulse-therapy. The treatment was followed by monthly administration of human normal immunoglobulin – 0.4 g per 1 kg of body mass within 24 months as a method of ADEM monotherapy. The positive dynamics of clinical symptoms was recorded 5 days after the beginning of the treatment (tendon anisoreflexia and swaying reduced). The treatment was followed by monthly administration of human normal immunoglobulin in the dose of 0.4 mg/kg. Three, nine and eighteen months after the beginning of the treatment the patient had two more MRI investigations of the brain that showed positive dynamics of the disease: reduction of demyelination foci and no accumulation of contrast agents. Her neurological deficits disappeared completely in 3 months. No relapses were observed over 24 months of observation. Conclusion: This case report confirms a positive therapeutic efficacy of intravenous immunoglobulin in the treatment of patient with ADEM – reduction of clinical manifestations of the disease, in particular a decrease in neurological deficit level. Monthly intravenous immunoglobulin administration also helps to prevent the disease relapses (multiphase ADEM course).
Authors and Affiliations
Iryna Lobanova
Mauriac Syndrome in a 35 Year Old Woman With Type One Diabetes Mellitus
Mauriac syndrome is a rare complication of type 1 diabetes mellitus. It is characterized by hepatomegaly, growth delay and the presence of elevated transaminases and serum lipids. Mauriac syndrome occurs in males and fem...
Hypercalcemia in Malignancy; the Second Great Masquerader
Hypercalcemia in malignancy can present with metabolic derangement, generalized weakness, altered mental status, renal compromise, cardiac dysrhythmias including atrial fibrillation and bradycardia, abdominal pain and/or...
Gorlin Goltz Syndrome – A Case Report from Bosnia and Herzegovina
Gorlin-Goltz syndrome (GGS) is an uncommon inherited disorder characterized by numerous basal cell carcinomas, odontogenic keratocysts and musculoskeletal malformations. A spectrum of other neurological, ophthalmic, endo...
Detection of Metastatic Lung Cancer by Immunocytochemistry and Flow Cytometry in a Sample of Pleural Fluid
Malignant pleural effusions (MPE) are common complications in cancer patients and indicate the spread of the primary disease (metastasis). For over a century, malignant effusion has been diagnosed through the observation...
Surgical Management of Oral Verrucous Carcinoma and Its Recurrence: A Case Report and an Update
Aim: To enlighten and update the clinicians about the diagnosis and management of recurrent verrucous carcinoma. Presentation of Case: A single case of Oral verrucous carcinoma of the alveolar ridge is reported. The pat...